CIK 0001107421
- Non-accelerated filer
- Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841475642
- Phone
- +1 346-355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award CEO acquired 150,000 shares (grant or award)
- 4 Grant or award President, COO & Treasurer acquired 50,000 shares (grant or award)
- 4 Open-market buy Director bought 175,000 shares at $3.10 ($542,500)
- 4 Open-market buy Director bought 50,000 shares at $3.10 ($155,000)
- 4 Open-market buy 10% owner bought 457,766 shares at an average $2.18 ($999,898)
- 4 Shares withheld for taxes CEO gave up 47,625 shares (to pay taxes)
- 4 Shares withheld for taxes President, COO & Treasurer gave up 15,875 shares (to pay taxes)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award CEO acquired 300,000 shares (grant or award)
- 4 Grant or award President, COO & Treasurer acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Open-market buy Director bought 50,000 shares at $1.83 ($91,250)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 19 of 24 · 465 filings